Underperform rating was given by 0 analysts and Outperform rating was given by 9 analysts. MU Investments Co. Ltd. acquired a new stake in shares of Walgreens Boots Alliance during the second quarter worth approximately $150,000. Jolley Asset Management LLC raised its position in Walgreens Boots Alliance by 104.5% in the second quarter. Ngam Advisors L.P. increased its position in Walgreens Boots Alliance by 46.2% in the second quarter. Markston International LLC now owns 197,648 shares of the pharmacy operator's stock valued at $16,458,000 after buying an additional 8,703 shares in the last quarter. Sumitomo Mitsui Trust Holdings Inc. boosted its stake in Walgreens Boots Alliance by 5.5% in the second quarter. Everence Capital Management Inc. now owns 13,012 shares of the pharmacy operator's stock valued at $1,084,000 after buying an additional 6,830 shares during the last quarter. The return on equity ratio or ROE stands at 6.6 percent while most common profitability ratio return on investment (ROI) was 4.8 percent.
03/01/2016 - Walgreens Boots Alliance, Inc. was upgraded to "buy" by analysts at Mizuho. If a company's earnings are much lower than expected, the company's stock may gap down before the next trading session. The company has the market capitalization of $1.9 Billion. The firm has a SMA 50 (Simple Moving Average) of 0.96% and a SMA 200-(Simple Moving Average) of 1.85%.
RAD was trading -21.57% below its 52-week high and -1.06% below its 52-week low. If you are reading this story on another website, that means this article was illegally copied and re-published to this website in violation of USA and worldwide copyright law.
Earnings Overview For Walgreens Boots Alliance, Inc.
Indeed, earnings growth is among the most critical things to look at in regards to stock investing and, accordingly, investors identify companies that have grown their earnings by at least 25% for a 3 year period. The firm earned $28.60 billion during the quarter, compared to analysts' expectations of $29.06 billion. Walgreens Boots Alliance had a return on equity of 16.33% and a net margin of 3.56%. As stated above, it has an EPS growth projection for the next five years of 12.35%.
On the company's financial health, Walgreens Boots Alliance Inc reported $1.07 EPS for the quarter, beating the analyst consensus estimate by $ 0.08 according to the earnings call on Oct 20, 2016. Harrison Partners Inc reduced its stake in WBA by selling 2,000 shares or 5.44% in the most recent quarter.
The firm also recently announced a quarterly dividend, which will be paid on Monday, December 12th. Shareholders of record on Thursday, November 17th will be given a dividend of $0.375 per share. The company has an Average Rating of 2.45 based on Thomson Reuters I/B/E/S scale of 1-5. The ex-dividend date of this dividend is Tuesday, November 15th. Walgreens Boots Alliance, Inc. has P/S value of 0.77 while its P/B value stands at 3. Analysts mean target price for Oclaro, Inc. Target predictions might differ vastly from analyst to analyst.
Shares of Walgreens Boots Alliance (NASDAQ:WBA) traded down 0.29% on Monday, reaching $82.49. The stock has "Outperform" rating given by Credit Suisse on Monday, July 18.
Recently analysts working for a variety of stock market brokerages have changed their consensus ratings and price targets on shares of Walgreens Boots Alliance, Inc. The company has an average rating of "Buy" and an average target price of $93.01. Its EVP and Global Chief HRO Wilson-Thompson Kathleen sold 23,996 company shares for $2039000.66, in a transaction on 2016-09-08.
A gap is a space between prices that happens when the stock price makes a move down or up when there is no trading happening in between. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. For the period which closed on 2016-08-31, Walgreens Boots Alliance, Inc. The Firm is a pharmacy-led health and wellbeing company.
Earnings Estimates for Walgreens Boots Alliance, Inc. Its portfolio of retail and business brands includes Walgreens Duane Reade Boots and Alliance Healthcare as well as global health and beauty product brands including No7 Botanics and Soap & Glory.
Zacks also gives an average broker rating based on the sell-side recommendations from the analysts who cover Walgreens Boots Alliance, Inc.